Vimarsana
Biggest News Aggregation in the World

Page 36 - Pharma Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Services Today - Breaking & Trending Today

PCI Pharma Services Announces New Sterile Fill-Finish - Vimarsana News

PCI Pharma Services Announces New Sterile Fill-Finish

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced that three new...

PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego - Vimarsana News

PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego

New equipment added to San Diego and Melbourne facilities will help with clinical scale and global capacity shortages

Pharmaceutical company expanding, bringing more jobs to Rockford - Vimarsana News

Pharmaceutical company expanding, bringing more jobs to Rockford

PCI Pharma Services will break ground on a $50 million facility this year. Learn what's coming and what kind of impact that will have.

Source: rrstar.com
Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) Price Target at $18.89 - Vimarsana News

Brokerages Set NeoGenomics, Inc. (NASDAQ:NEO) Price Target at $18.89

NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the thirteen analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and eight have issued a buy recommendation on the company. The average […]

NeoGenomics (NASDAQ:NEO) Releases FY 2023 Earnings Guidance - Vimarsana News

NeoGenomics (NASDAQ:NEO) Releases FY 2023 Earnings Guidance

NeoGenomics (NASDAQ:NEO – Get Rating) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share guidance of -$0.38–$0.32 for the period, compared to the consensus earnings per share estimate of -$0.44. The company issued revenue guidance of $545.00 million-$555.00 million, compared to the consensus revenue estimate of […]